U.S. Supreme Court and the Abortion Pill Debate intermediate

Emergency room doctors are a crucial component of the mifepristone regimen, according to the Alliance for Hippocratic Medicine

The Biden administration argues that the group challenging the FDA failed to show any evidence of injury from the availability of the medication

Danco, the maker of abortion pill Mifeprex, is against the group challenging the FDA

The government maintains that the FDA's scientific judgment has been consistent across five presidential administrations

The Fifth Circuit's decision is supported by the White House spokeswoman Karine Jean-Pierre

True or false: The U.S. Supreme Court has agreed to review a lower court decision regarding the accessibility of the commonly used abortion pill, mifepristone?

True or false: The FDA has required the abortion pill, mifepristone, to be prescribed in person over three visits to a doctor since its approval in 2000?

True or false: Since 2016, the FDA has allowed patients to obtain prescriptions for mifepristone through telemedicine appointments and to get the drug by mail?

True or false: U.S. District Judge Matthew Kacsmaryk imposed a nationwide ban on mifepristone, declaring that the FDA had properly approved the drug 23 years ago?

True or false: U.S. District Judge Thomas O. Rice in Washington state issued a ruling in favor of expanding the use of mifepristone, declaring that the current FDA rules must remain in place?